Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Gubinelli

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Parkinson'S Disease|February 25, 2022
Sequential or Simultaneous Injection of Preformed Fibrils and AAV Overexpression of Alpha-Synuclein Are Equipotent in Producing Relevant Pathology and Behavioral DeficitsMatilde Negrini, Giuseppe Tomasello, Marcus Davidsson, et al.
Journal of Virological Methods|October 9, 2017
Strategies to obtain multiple recombinant modified vaccinia Ankara vectors. Applications to influenza vaccinesAndrea Barbieri, Maddalena Panigada, Elisa Soprana, et al.
Pathogens and Global Health|January 13, 2017
Protective immunity against influenza in HLA-A2 transgenic mice by modified vaccinia virus Ankara vectored vaccines containing internal influenza proteinsGiuseppina Di Mario, Ester Sciaraffia, Marzia Facchini, et al.
Pathogens and Global Health|January 14, 2017
Immunogenicity of modified vaccinia virus Ankara expressing the hemagglutinin stalk domain of pandemic (H1N1) 2009 influenza virusGiuseppina Di Mario, Elisa Soprana, Francesco Gubinelli, et al.
Science Advances|February 11, 2026
VMAT2 dysfunction impairs vesicular dopamine uptake, driving its oxidation and α-synuclein pathology in DJ-1-linked Parkinson's neuronsLeonie M Heger, Francesco Gubinelli, Andreas J Huber, et al.
Vaccine|June 21, 2023
Assessing the stability-indicating properties of alternative potency assays for inactivated influenza vaccineAleksei Ekimov, Arun B Arunachalam, Taylor Blake, et al.
Plos One|May 1, 2023
A comparison of machine learning approaches for the quantification of microglial cells in the brain of mice, rats and non-human primatesDanish M Anwer, Francesco Gubinelli, Yunus A Kurt, et al.
Neurobiology of Disease|October 13, 2019
The C-terminal domain of LRRK2 with the G2019S mutation is sufficient to produce neurodegeneration of dopaminergic neurons in vivoNoémie Cresto, Marie-Claude Gaillard, Camille Gardier, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 15, 2025
Patient-Derived Neurons Exhibit α-Synuclein Pathology and Previously Unrecognized Major Histocompatibility Complex Class I Elevation in Mitochondrial Membrane Protein-Associated NeurodegenerationLeonie M Heger, Leonie Kertess, Clara Kaufhold, et al.
International Journal of Molecular Sciences|July 2, 2021
The C-Terminal Domain of LRRK2 with the G2019S Substitution Increases Mutant A53T α-Synuclein Toxicity in Dopaminergic Neurons In VivoNoémie Cresto, Camille Gardier, Marie-Claude Gaillard, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Parkinson'S Disease|February 25, 2022
Sequential or Simultaneous Injection of Preformed Fibrils and AAV Overexpression of Alpha-Synuclein Are Equipotent in Producing Relevant Pathology and Behavioral DeficitsMatilde Negrini, Giuseppe Tomasello, Marcus Davidsson, et al.
Journal of Virological Methods|October 9, 2017
Strategies to obtain multiple recombinant modified vaccinia Ankara vectors. Applications to influenza vaccinesAndrea Barbieri, Maddalena Panigada, Elisa Soprana, et al.
Pathogens and Global Health|January 13, 2017
Protective immunity against influenza in HLA-A2 transgenic mice by modified vaccinia virus Ankara vectored vaccines containing internal influenza proteinsGiuseppina Di Mario, Ester Sciaraffia, Marzia Facchini, et al.
Pathogens and Global Health|January 14, 2017
Immunogenicity of modified vaccinia virus Ankara expressing the hemagglutinin stalk domain of pandemic (H1N1) 2009 influenza virusGiuseppina Di Mario, Elisa Soprana, Francesco Gubinelli, et al.
Science Advances|February 11, 2026
VMAT2 dysfunction impairs vesicular dopamine uptake, driving its oxidation and α-synuclein pathology in DJ-1-linked Parkinson's neuronsLeonie M Heger, Francesco Gubinelli, Andreas J Huber, et al.
Vaccine|June 21, 2023
Assessing the stability-indicating properties of alternative potency assays for inactivated influenza vaccineAleksei Ekimov, Arun B Arunachalam, Taylor Blake, et al.
Plos One|May 1, 2023
A comparison of machine learning approaches for the quantification of microglial cells in the brain of mice, rats and non-human primatesDanish M Anwer, Francesco Gubinelli, Yunus A Kurt, et al.
Neurobiology of Disease|October 13, 2019
The C-terminal domain of LRRK2 with the G2019S mutation is sufficient to produce neurodegeneration of dopaminergic neurons in vivoNoémie Cresto, Marie-Claude Gaillard, Camille Gardier, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 15, 2025
Patient-Derived Neurons Exhibit α-Synuclein Pathology and Previously Unrecognized Major Histocompatibility Complex Class I Elevation in Mitochondrial Membrane Protein-Associated NeurodegenerationLeonie M Heger, Leonie Kertess, Clara Kaufhold, et al.
International Journal of Molecular Sciences|July 2, 2021
The C-Terminal Domain of LRRK2 with the G2019S Substitution Increases Mutant A53T α-Synuclein Toxicity in Dopaminergic Neurons In VivoNoémie Cresto, Camille Gardier, Marie-Claude Gaillard, et al.
Pageof 2